UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY
INVESTMENT COMPANY ACT FILE NUMBER: 811-03386
EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER: Putnam Global Health Care Fund
100 FEDERAL STREET, BOSTON, MASSACHUSETTS USA 02110
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)(ZIP CODE)
STEPHEN J. TATE, VICE PRESIDENT, 100 FEDERAL ST, MASSACHUSETTS USA 02110
CC:
BRYAN CHEGWIDDEN, ESQ., ROPES & GRAY LLP, 1211 AVENUE OF THE AMERICAS, NEW YORK, NEW YORK 10036
(NAME AND ADDRESS OF AGENT FOR SERVICE)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: 617-292-1000
DATE OF FISCAL YEAR END: 08/31
DATE OF REPORTING PERIOD: 07/01/2021 - 06/30/2022
Putnam Global Health Care Fund
4FRONT VENTURES CORP.
Meeting Date: DEC 07, 2021 Record Date: OCT 22, 2021 Meeting Type: ANNUAL |
||||
Ticker: FFNT
Security ID: 35086B207 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Fix Number of Directors at Six | Management | For | For |
2.1 | Elect Director David Daily | Management | For | For |
2.2 | Elect Director Leonid Gontmakher | Management | For | For |
2.3 | Elect Director Chetan Gulati | Management | For | For |
2.4 | Elect Director Kathi Lentzsch | Management | For | Withhold |
2.5 | Elect Director Eric Rey | Management | For | For |
2.6 | Elect Director Roman Tkachenko | Management | For | For |
3 | Approve Davidson & Company LLP as Auditors and Authorize Board to Fix Their Remuneration | Management | For | For |
4FRONT VENTURES CORP.
Meeting Date: JUN 22, 2022 Record Date: MAY 06, 2022 Meeting Type: ANNUAL |
||||
Ticker: FFNT
Security ID: 35086B207 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Fix Number of Directors at Seven | Management | For | For |
2.1 | Elect Director David Daily | Management | For | For |
2.2 | Elect Director Leonid Gontmakher | Management | For | For |
2.3 | Elect Director Chetan Gulati | Management | For | For |
2.4 | Elect Director Robert Hunt | Management | For | For |
2.5 | Elect Director Kathi Lentzsch | Management | For | Withhold |
2.6 | Elect Director Amit Patel | Management | For | For |
2.7 | Elect Director Roman Tkachenko | Management | For | For |
3 | Approve Davidson & Company LLP as Auditors and Authorize Board to Fix Their Remuneration | Management | For | For |
ABBOTT LABORATORIES
Meeting Date: APR 29, 2022 Record Date: MAR 02, 2022 Meeting Type: ANNUAL |
||||
Ticker: ABT
Security ID: 002824100 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | Elect Director Robert J. Alpern | Management | For | For |
1.2 | Elect Director Sally E. Blount | Management | For | For |
1.3 | Elect Director Robert B. Ford | Management | For | For |
1.4 | Elect Director Paola Gonzalez | Management | For | For |
1.5 | Elect Director Michelle A. Kumbier | Management | For | For |
1.6 | Elect Director Darren W. McDew | Management | For | For |
1.7 | Elect Director Nancy McKinstry | Management | For | For |
1.8 | Elect Director William A. Osborn | Management | For | For |
1.9 | Elect Director Michael F. Roman | Management | For | For |
1.10 | Elect Director Daniel J. Starks | Management | For | For |
1.11 | Elect Director John G. Stratton | Management | For | For |
1.12 | Elect Director Glenn F. Tilton | Management | For | For |
2 | Ratify Ernst & Young LLP as Auditors | Management | For | For |
3 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
4 | Reduce Ownership Threshold for Shareholders to Call Special Meeting | Shareholder | Against | Against |
5 | Require Independent Board Chair | Shareholder | Against | Against |
6 | Adopt Policy on 10b5-1 Plans | Shareholder | Against | Against |
7 | Report on Lobbying Payments and Policy | Shareholder | Against | Against |
8 | Report on Public Health Costs of Antimicrobial Resistance | Shareholder | Against | Against |
ABBVIE INC.
Meeting Date: MAY 06, 2022 Record Date: MAR 07, 2022 Meeting Type: ANNUAL |
||||
Ticker: ABBV
Security ID: 00287Y109 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | Elect Director William H.L. Burnside | Management | For | For |
1.2 | Elect Director Thomas C. Freyman | Management | For | For |
1.3 | Elect Director Brett J. Hart | Management | For | For |
1.4 | Elect Director Edward J. Rapp | Management | For | For |
2 | Ratify Ernst & Young LLP as Auditors | Management | For | For |
3 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
4 | Eliminate Supermajority Vote Requirement | Management | For | For |
5 | Require Independent Board Chair | Shareholder | Against | Against |
6 | Submit Severance Agreement (Change-in-Control) to Shareholder Vote | Shareholder | Against | Against |
7 | Report on Board Oversight of Risks Related to Anticompetitive Practices | Shareholder | Against | Against |
8 | Report on Congruency of Political Spending with Company Values and Priorities | Shareholder | Against | Against |
AMERISOURCEBERGEN CORPORATION
Meeting Date: MAR 10, 2022 Record Date: JAN 10, 2022 Meeting Type: ANNUAL |
||||
Ticker: ABC
Security ID: 03073E105 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Ornella Barra | Management | For | For |
1b | Elect Director Steven H. Collis | Management | For | For |
1c | Elect Director D. Mark Durcan | Management | For | For |
1d | Elect Director Richard W. Gochnauer | Management | For | For |
1e | Elect Director Lon R. Greenberg | Management | For | For |
1f | Elect Director Jane E. Henney | Management | For | For |
1g | Elect Director Kathleen W. Hyle | Management | For | For |
1h | Elect Director Michael J. Long | Management | For | For |
1i | Elect Director Henry W. McGee | Management | For | For |
1j | Elect Director Dennis M. Nally | Management | For | For |
2 | Ratify Ernst & Young LLP as Auditors | Management | For | For |
3 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
4 | Approve Omnibus Stock Plan | Management | For | For |
5 | Adopt a Policy That No Financial Metric Be Adjusted to Exclude Legal or Compliance Costs in Determining Executive Compensation | Shareholder | Against | Against |
6 | Reduce Ownership Threshold for Shareholders to Call Special Meeting | Shareholder | Against | Against |
ANTHEM, INC.
Meeting Date: MAY 18, 2022 Record Date: MAR 17, 2022 Meeting Type: ANNUAL |
||||
Ticker: ANTM
Security ID: 036752103 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | Elect Director Susan D. DeVore | Management | For | For |
1.2 | Elect Director Bahija Jallal | Management | For | For |
1.3 | Elect Director Ryan M. Schneider | Management | For | For |
1.4 | Elect Director Elizabeth E. Tallett | Management | For | For |
2 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
3 | Ratify Ernst & Young LLP as Auditors | Management | For | For |
4 | Change Company Name to Elevance Health, Inc. | Management | For | For |
5 | Adopt a Policy Prohibiting Direct and Indirect Political Contributions to Candidates | Shareholder | Against | Against |
6 | Oversee and Report a Racial Equity Audit | Shareholder | Against | Against |
ASCENDIS PHARMA A/S
Meeting Date: NOV 18, 2021 Record Date: OCT 21, 2021 Meeting Type: EXTRAORDINARY SHAREHOLDERS |
||||
Ticker: ASND
Security ID: 04351P101 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Elect Chairman of Meeting | Management | For | Did Not Vote |
2 | Elect Rafaele Tordjman as Director | Management | For | Did Not Vote |
3 | Authorize Editorial Changes to Adopted Resolutions in Connection with Registration with Danish Authorities | Management | For | Did Not Vote |
ASCENDIS PHARMA A/S
Meeting Date: MAY 30, 2022 Record Date: APR 22, 2022 Meeting Type: ANNUAL |
||||
Ticker: ASND
Security ID: 04351P101 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Elect Chairman of Meeting | Management | For | Did Not Vote |
2 | Receive Company Activity Report | Management | For | Did Not Vote |
3 | Accept Financial Statements and Statutory Reports; Approve Discharge of Management and Board | Management | For | Did Not Vote |
4 | Approve Treatment of Net Loss | Management | For | Did Not Vote |
5a | Reelect Albert Cha as Director For Two Years Term | Management | For | Did Not Vote |
5b | Reelect Rafaele Tordjman as Director For Two Years Term | Management | For | Did Not Vote |
5c | Reelect Lars Holtug as Director For Two Years Term | Management | For | Did Not Vote |
6 | Ratify Deloitte as Auditors | Management | For | Did Not Vote |
7a | Approve Issuance of Convertible Loan Instruments without Preemptive Rights; Approve Creation of DKK 1 Million Pool of Capital to Guarantee Conversion Rights | Management | For | Did Not Vote |
7b | Approve Warrant Plan | Management | For | Did Not Vote |
ASTELLAS PHARMA, INC.
Meeting Date: JUN 20, 2022 Record Date: MAR 31, 2022 Meeting Type: ANNUAL |
||||
Ticker: 4503
Security ID: J03393105 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Amend Articles to Disclose Shareholder Meeting Materials on Internet | Management | For | For |
2.1 | Elect Director Yasukawa, Kenji | Management | For | For |
2.2 | Elect Director Okamura, Naoki | Management | For | For |
2.3 | Elect Director Sekiyama, Mamoru | Management | For | For |
2.4 | Elect Director Kawabe, Hiroshi | Management | For | For |
2.5 | Elect Director Tanaka, Takashi | Management | For | For |
2.6 | Elect Director Sakurai, Eriko | Management | For | For |
3.1 | Elect Director and Audit Committee Member Yoshimitsu, Toru | Management | For | For |
3.2 | Elect Director and Audit Committee Member Takahashi, Raita | Management | For | For |
3.3 | Elect Director and Audit Committee Member Nakayama, Mika | Management | For | For |
ASTRAZENECA PLC
Meeting Date: APR 29, 2022 Record Date: APR 27, 2022 Meeting Type: ANNUAL |
||||
Ticker: AZN
Security ID: G0593M107 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Accept Financial Statements and Statutory Reports | Management | For | For |
2 | Approve Dividends | Management | For | For |
3 | Reappoint PricewaterhouseCoopers LLP as Auditors | Management | For | For |
4 | Authorise Board to Fix Remuneration of Auditors | Management | For | For |
5a | Re-elect Leif Johansson as Director | Management | For | For |
5b | Re-elect Pascal Soriot as Director | Management | For | For |
5c | Elect Aradhana Sarin as Director | Management | For | For |
5d | Re-elect Philip Broadley as Director | Management | For | For |
5e | Re-elect Euan Ashley as Director | Management | For | For |
5f | Re-elect Michel Demare as Director | Management | For | For |
5g | Re-elect Deborah DiSanzo as Director | Management | For | For |
5h | Re-elect Diana Layfield as Director | Management | For | For |
5i | Re-elect Sheri McCoy as Director | Management | For | For |
5j | Re-elect Tony Mok as Director | Management | For | For |
5k | Re-elect Nazneen Rahman as Director | Management | For | For |
5l | Elect Andreas Rummelt as Director | Management | For | For |
5m | Re-elect Marcus Wallenberg as Director | Management | For | For |
6 | Approve Remuneration Report | Management | For | For |
7 | Authorise UK Political Donations and Expenditure | Management | For | For |
8 | Authorise Issue of Equity | Management | For | For |
9 | Authorise Issue of Equity without Pre-emptive Rights | Management | For | For |
10 | Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment | Management | For | For |
11 | Authorise Market Purchase of Ordinary Shares | Management | For | For |
12 | Authorise the Company to Call General Meeting with Two Weeks' Notice | Management | For | Against |
13 | Approve Savings Related Share Option Scheme | Management | For | For |
BAXTER INTERNATIONAL INC.
Meeting Date: MAY 03, 2022 Record Date: MAR 11, 2022 Meeting Type: ANNUAL |
||||
Ticker: BAX
Security ID: 071813109 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Jose (Joe) E. Almeida | Management | For | For |
1b | Elect Director Thomas F. Chen | Management | For | For |
1c | Elect Director Peter S. Hellman | Management | For | For |
1d | Elect Director Michael F. Mahoney | Management | For | For |
1e | Elect Director Patricia B. Morrison | Management | For | For |
1f | Elect Director Stephen N. Oesterle | Management | For | For |
1g | Elect Director Nancy M. Schlichting | Management | For | For |
1h | Elect Director Cathy R. Smith | Management | For | For |
1i | Elect Director Albert P.L. Stroucken | Management | For | For |
1j | Elect Director Amy A. Wendell | Management | For | For |
1k | Elect Director David S. Wilkes | Management | For | For |
2 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
3 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | For | For |
4 | Provide Right to Act by Written Consent | Management | For | For |
5 | Reduce Ownership Threshold for Special Shareholder Meetings to 15% | Management | For | For |
6 | Reduce Ownership Threshold for Special Shareholder Meetings to 10% | Shareholder | Against | Against |
7 | Require Independent Board Chair | Shareholder | Against | Against |
BOSTON SCIENTIFIC CORPORATION
Meeting Date: MAY 05, 2022 Record Date: MAR 11, 2022 Meeting Type: ANNUAL |
||||
Ticker: BSX
Security ID: 101137107 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Nelda J. Connors | Management | For | For |
1b | Elect Director Charles J. Dockendorff | Management | For | For |
1c | Elect Director Yoshiaki Fujimori | Management | For | For |
1d | Elect Director Donna A. James | Management | For | For |
1e | Elect Director Edward J. Ludwig | Management | For | For |
1f | Elect Director Michael F. Mahoney | Management | For | For |
1g | Elect Director David J. Roux | Management | For | For |
1h | Elect Director John E. Sununu | Management | For | For |
1i | Elect Director David S. Wichmann | Management | For | For |
1j | Elect Director Ellen M. Zane | Management | For | For |
2 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
3 | Ratify Ernst & Young LLP as Auditors | Management | For | For |
4 | Amend Qualified Employee Stock Purchase Plan | Management | For | For |
CHUGAI PHARMACEUTICAL CO., LTD.
Meeting Date: MAR 29, 2022 Record Date: DEC 31, 2021 Meeting Type: ANNUAL |
||||
Ticker: 4519
Security ID: J06930101 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Approve Allocation of Income, with a Final Dividend of JPY 46 | Management | For | For |
2 | Amend Articles to Disclose Shareholder Meeting Materials on Internet | Management | For | For |
3.1 | Elect Director Okuda, Osamu | Management | For | For |
3.2 | Elect Director Yamada, Hisafumi | Management | For | For |
3.3 | Elect Director Itagaki, Toshiaki | Management | For | For |
3.4 | Elect Director Momoi, Mariko | Management | For | For |
COLUMBIA CARE INC.
Meeting Date: JUL 02, 2021 Record Date: JUN 02, 2021 Meeting Type: ANNUAL/SPECIAL |
||||
Ticker: CCHW
Security ID: 197309107 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Nicholas Vita | Management | For | For |
1b | Elect Director Michael Abbott | Management | For | For |
1c | Elect Director Frank Savage | Management | For | For |
1d | Elect Director James A.C. Kennedy | Management | For | For |
1e | Elect Director Jonathan P. May | Management | For | For |
1f | Elect Director Jeff Clarke | Management | For | For |
1g | Elect Director Alison Worthington | Management | For | For |
1h | Elect Director Julie Hill | Management | For | For |
2 | Approve Davidson & Company LLP as Auditors and Authorize Board to Fix Their Remuneration | Management | For | For |
3 | Amend Omnibus Plan | Management | For | Against |
CVS HEALTH CORPORATION
Meeting Date: MAY 11, 2022 Record Date: MAR 14, 2022 Meeting Type: ANNUAL |
||||
Ticker: CVS
Security ID: 126650100 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Fernando Aguirre | Management | For | For |
1b | Elect Director C. David Brown, II | Management | For | For |
1c | Elect Director Alecia A. DeCoudreaux | Management | For | For |
1d | Elect Director Nancy-Ann M. DeParle | Management | For | For |
1e | Elect Director Roger N. Farah | Management | For | For |
1f | Elect Director Anne M. Finucane | Management | For | For |
1g | Elect Director Edward J. Ludwig | Management | For | For |
1h | Elect Director Karen S. Lynch | Management | For | For |
1i | Elect Director Jean-Pierre Millon | Management | For | For |
1j | Elect Director Mary L. Schapiro | Management | For | For |
1k | Elect Director William C. Weldon | Management | For | For |
2 | Ratify Ernst & Young LLP as Auditors | Management | For | For |
3 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
4 | Reduce Ownership Threshold for Shareholders to Call Special Meeting | Shareholder | Against | Against |
5 | Require Independent Board Chair | Shareholder | Against | Against |
6 | Commission a Workplace Non-Discrimination Audit | Shareholder | Against | Against |
7 | Adopt a Policy on Paid Sick Leave for All Employees | Shareholder | Against | Against |
8 | Report on External Public Health Costs and Impact on Diversified Shareholders | Shareholder | Against | Against |
DAIICHI SANKYO CO., LTD.
Meeting Date: JUN 27, 2022 Record Date: MAR 31, 2022 Meeting Type: ANNUAL |
||||
Ticker: 4568
Security ID: J11257102 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Approve Allocation of Income, with a Final Dividend of JPY 13.5 | Management | For | For |
2 | Amend Articles to Disclose Shareholder Meeting Materials on Internet | Management | For | For |
3.1 | Elect Director Manabe, Sunao | Management | For | For |
3.2 | Elect Director Hirashima, Shoji | Management | For | For |
3.3 | Elect Director Otsuki, Masahiko | Management | For | For |
3.4 | Elect Director Okuzawa, Hiroyuki | Management | For | For |
3.5 | Elect Director Uji, Noritaka | Management | For | For |
3.6 | Elect Director Kama, Kazuaki | Management | For | For |
3.7 | Elect Director Nohara, Sawako | Management | For | For |
3.8 | Elect Director Fukuoka, Takashi | Management | For | For |
3.9 | Elect Director Komatsu, Yasuhiro | Management | For | For |
4.1 | Appoint Statutory Auditor Imazu, Yukiko | Management | For | For |
4.2 | Appoint Statutory Auditor Matsumoto, Mitsuhiro | Management | For | For |
5 | Approve Trust-Type Equity Compensation Plan | Management | For | For |
DANAHER CORPORATION
Meeting Date: MAY 10, 2022 Record Date: MAR 11, 2022 Meeting Type: ANNUAL |
||||
Ticker: DHR
Security ID: 235851102 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Rainer M. Blair | Management | For | For |
1b | Elect Director Linda Filler | Management | For | For |
1c | Elect Director Teri List | Management | For | For |
1d | Elect Director Walter G. Lohr, Jr. | Management | For | For |
1e | Elect Director Jessica L. Mega | Management | For | For |
1f | Elect Director Mitchell P. Rales | Management | For | For |
1g | Elect Director Steven M. Rales | Management | For | For |
1h | Elect Director Pardis C. Sabeti | Management | For | For |
1i | Elect Director A. Shane Sanders | Management | For | For |
1j | Elect Director John T. Schwieters | Management | For | For |
1k | Elect Director Alan G. Spoon | Management | For | For |
1l | Elect Director Raymond C. Stevens | Management | For | For |
1m | Elect Director Elias A. Zerhouni | Management | For | For |
2 | Ratify Ernst & Young LLP as Auditors | Management | For | For |
3 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
4 | Reduce Ownership Threshold for Shareholders to Call Special Meeting | Shareholder | Against | Against |
DEXCOM, INC.
Meeting Date: MAY 19, 2022 Record Date: MAR 31, 2022 Meeting Type: ANNUAL |
||||
Ticker: DXCM
Security ID: 252131107 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | Elect Director Steven R. Altman | Management | For | For |
1.2 | Elect Director Barbara E. Kahn | Management | For | For |
1.3 | Elect Director Kyle Malady | Management | For | For |
1.4 | Elect Director Jay S. Skyler | Management | For | For |
2 | Ratify Ernst & Young LLP as Auditors | Management | For | For |
3 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
4 | Approve Forward Stock Split | Management | For | For |
EDWARDS LIFESCIENCES CORPORATION
Meeting Date: MAY 03, 2022 Record Date: MAR 09, 2022 Meeting Type: ANNUAL |
||||
Ticker: EW
Security ID: 28176E108 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | Elect Director Kieran T. Gallahue | Management | For | For |
1.2 | Elect Director Leslie S. Heisz | Management | For | For |
1.3 | Elect Director Paul A. LaViolette | Management | For | For |
1.4 | Elect Director Steven R. Loranger | Management | For | For |
1.5 | Elect Director Martha H. Marsh | Management | For | For |
1.6 | Elect Director Michael A. Mussallem | Management | For | For |
1.7 | Elect Director Ramona Sequeira | Management | For | For |
1.8 | Elect Director Nicholas J. Valeriani | Management | For | For |
2 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
3 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | For | For |
4 | Reduce Ownership Threshold for Shareholders to Call Special Meeting | Shareholder | Against | Against |
EISAI CO., LTD.
Meeting Date: JUN 17, 2022 Record Date: MAR 31, 2022 Meeting Type: ANNUAL |
||||
Ticker: 4523
Security ID: J12852117 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Amend Articles to Disclose Shareholder Meeting Materials on Internet | Management | For | For |
2.1 | Elect Director Naito, Haruo | Management | For | For |
2.2 | Elect Director Kato, Yasuhiko | Management | For | For |
2.3 | Elect Director Kaihori, Shuzo | Management | For | For |
2.4 | Elect Director Uchiyama, Hideyo | Management | For | For |
2.5 | Elect Director Hayashi, Hideki | Management | For | For |
2.6 | Elect Director Miwa, Yumiko | Management | For | For |
2.7 | Elect Director Ike, Fumihiko | Management | For | For |
2.8 | Elect Director Kato, Yoshiteru | Management | For | For |
2.9 | Elect Director Miura, Ryota | Management | For | For |
2.10 | Elect Director Kato, Hiroyuki | Management | For | For |
2.11 | Elect Director Richard Thornley | Management | For | For |
ELI LILLY AND COMPANY
Meeting Date: MAY 02, 2022 Record Date: FEB 22, 2022 Meeting Type: ANNUAL |
||||
Ticker: LLY
Security ID: 532457108 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Ralph Alvarez | Management | For | For |
1b | Elect Director Kimberly H. Johnson | Management | For | For |
1c | Elect Director Juan R. Luciano | Management | For | For |
2 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
3 | Ratify Ernst & Young LLP as Auditors | Management | For | For |
4 | Declassify the Board of Directors | Management | For | For |
5 | Eliminate Supermajority Voting Provisions | Management | For | For |
6 | Amend Articles of Incorporation to Allow Shareholders to Amend Bylaws | Management | For | For |
7 | Require Independent Board Chair | Shareholder | Against | Against |
8 | Report on Lobbying Payments and Policy | Shareholder | Against | Against |
9 | Publish Third-Party Review of Alignment of Company's Lobbying Activities with its Public Statements | Shareholder | Against | Against |
10 | Report on Board Oversight of Risks Related to Anticompetitive Pricing Strategies | Shareholder | Against | Against |
GREEN THUMB INDUSTRIES INC.
Meeting Date: JUN 16, 2022 Record Date: APR 22, 2022 Meeting Type: ANNUAL |
||||
Ticker: GTII
Security ID: 39342L108 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Fix Number of Directors at Six | Management | For | For |
2a | Elect Director Wendy Berger | Management | For | Withhold |
2b | Elect Director Anthony Georgiadis | Management | For | Withhold |
2c | Elect Director William Gruver | Management | For | Withhold |
2d | Elect Director Benjamin Kovler | Management | For | Withhold |
2e | Elect Director Dorri McWhorter | Management | For | Withhold |
2f | Elect Director Glen Senk | Management | For | Withhold |
3 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
4 | Advisory Vote on Say on Pay Frequency | Management | One Year | One Year |
5 | Approve Baker Tilly US LLP as Auditors and Authorize Board to Fix Their Remuneration | Management | For | For |
HCA HEALTHCARE, INC.
Meeting Date: APR 21, 2022 Record Date: FEB 25, 2022 Meeting Type: ANNUAL |
||||
Ticker: HCA
Security ID: 40412C101 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Thomas F. Frist, III | Management | For | For |
1b | Elect Director Samuel N. Hazen | Management | For | For |
1c | Elect Director Meg G. Crofton | Management | For | For |
1d | Elect Director Robert J. Dennis | Management | For | For |
1e | Elect Director Nancy-Ann DeParle | Management | For | For |
1f | Elect Director William R. Frist | Management | For | For |
1g | Elect Director Charles O. Holliday, Jr. | Management | For | For |
1h | Elect Director Hugh F. Johnston | Management | For | For |
1i | Elect Director Michael W. Michelson | Management | For | For |
1j | Elect Director Wayne J. Riley | Management | For | For |
1k | Elect Director Andrea B. Smith | Management | For | For |
2 | Ratify Ernst & Young LLP as Auditors | Management | For | For |
3 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
4 | Report on Political Contributions | Shareholder | Against | Against |
5 | Report on Lobbying Payments and Policy | Shareholder | Against | Against |
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
Meeting Date: APR 28, 2022 Record Date: FEB 24, 2022 Meeting Type: ANNUAL |
||||
Ticker: HZNP
Security ID: G46188101 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Michael Grey | Management | For | Against |
1b | Elect Director Jeff Himawan | Management | For | For |
1c | Elect Director Susan Mahony | Management | For | For |
2 | Ratify PricewaterhouseCoopers LLP as Auditors and Authorise Their Remuneration | Management | For | For |
3 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
4 | Authorize Market Purchases or Overseas Market Purchases of Ordinary Shares | Management | For | For |
5 | Amend Omnibus Stock Plan | Management | For | Against |
HUMANA INC.
Meeting Date: APR 21, 2022 Record Date: FEB 28, 2022 Meeting Type: ANNUAL |
||||
Ticker: HUM
Security ID: 444859102 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Raquel C. Bono | Management | For | For |
1b | Elect Director Bruce D. Broussard | Management | For | For |
1c | Elect Director Frank A. D'Amelio | Management | For | For |
1d | Elect Director David T. Feinberg | Management | For | For |
1e | Elect Director Wayne A. I. Frederick | Management | For | For |
1f | Elect Director John W. Garratt | Management | For | For |
1g | Elect Director Kurt J. Hilzinger | Management | For | For |
1h | Elect Director David A. Jones, Jr. | Management | For | For |
1i | Elect Director Karen W. Katz | Management | For | For |
1j | Elect Director Marcy S. Klevorn | Management | For | For |
1k | Elect Director William J. McDonald | Management | For | For |
1l | Elect Director Jorge S. Mesquita | Management | For | For |
1m | Elect Director James J. O'Brien | Management | For | For |
2 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | For | For |
3 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
ICON PLC
Meeting Date: JUL 20, 2021 Record Date: JUN 10, 2021 Meeting Type: ANNUAL |
||||
Ticker: ICLR
Security ID: G4705A100 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | Elect Director Ciaran Murray | Management | For | For |
1.2 | Elect Director Joan Garahy | Management | For | For |
1.3 | Elect Director Eugene McCague | Management | For | For |
2.1 | Elect Director Colin Shannon | Management | For | For |
2.2 | Elect Director Linda Grais | Management | For | For |
3 | Accept Financial Statements and Statutory Reports | Management | For | For |
4 | Authorize Board to Fix Remuneration of Auditors | Management | For | For |
5 | Authorize Issue of Equity | Management | For | For |
6 | Authorize Issue of Equity without Pre-emptive Rights | Management | For | For |
7 | Authorize Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment | Management | For | For |
8 | Authorize Share Repurchase Program | Management | For | For |
9 | Approve the Price Range for the Reissuance of Shares | Management | For | For |
ILLUMINA, INC.
Meeting Date: MAY 26, 2022 Record Date: MAR 31, 2022 Meeting Type: ANNUAL |
||||
Ticker: ILMN
Security ID: 452327109 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1A | Elect Director Frances Arnold | Management | For | For |
1B | Elect Director Francis A. deSouza | Management | For | For |
1C | Elect Director Caroline D. Dorsa | Management | For | For |
1D | Elect Director Robert S. Epstein | Management | For | For |
1E | Elect Director Scott Gottlieb | Management | For | For |
1F | Elect Director Gary S. Guthart | Management | For | For |
1G | Elect Director Philip W. Schiller | Management | For | For |
1H | Elect Director Susan E. Siegel | Management | For | For |
1I | Elect Director John W. Thompson | Management | For | For |
2 | Ratify Ernst & Young LLP as Auditors | Management | For | For |
3 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
4 | Provide Right to Call a Special Meeting at a 15 Percent Ownership Threshold | Shareholder | Against | For |
5 | Provide Right to Call Special Meeting | Management | For | For |
INNOVIVA, INC.
Meeting Date: APR 25, 2022 Record Date: MAR 10, 2022 Meeting Type: ANNUAL |
||||
Ticker: INVA
Security ID: 45781M101 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director George W. Bickerstaff, III | Management | For | For |
1b | Elect Director Deborah L. Birx | Management | For | For |
1c | Elect Director Mark A. DiPaolo | Management | For | For |
1d | Elect Director Jules Haimovitz | Management | For | For |
1e | Elect Director Odysseas D. Kostas | Management | For | For |
1f | Elect Director Sarah J. Schlesinger | Management | For | Against |
2 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
3 | Ratify Deloitte & Touche LLP as Auditors | Management | For | For |
INTUITIVE SURGICAL, INC.
Meeting Date: SEP 20, 2021 Record Date: AUG 18, 2021 Meeting Type: SPECIAL |
||||
Ticker: ISRG
Security ID: 46120E602 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Increase Authorized Common Stock | Management | For | For |
INTUITIVE SURGICAL, INC.
Meeting Date: APR 28, 2022 Record Date: MAR 01, 2022 Meeting Type: ANNUAL |
||||
Ticker: ISRG
Security ID: 46120E602 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Craig H. Barratt | Management | For | For |
1b | Elect Director Joseph C. Beery | Management | For | For |
1c | Elect Director Gary S. Guthart | Management | For | For |
1d | Elect Director Amal M. Johnson | Management | For | For |
1e | Elect Director Don R. Kania | Management | For | For |
1f | Elect Director Amy L. Ladd | Management | For | For |
1g | Elect Director Keith R. Leonard, Jr. | Management | For | For |
1h | Elect Director Alan J. Levy | Management | For | For |
1i | Elect Director Jami Dover Nachtsheim | Management | For | For |
1j | Elect Director Monica P. Reed | Management | For | For |
1k | Elect Director Mark J. Rubash | Management | For | For |
2 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
3 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | For | For |
4 | Amend Omnibus Stock Plan | Management | For | For |
IRONWOOD PHARMACEUTICALS, INC.
Meeting Date: JUN 01, 2022 Record Date: APR 06, 2022 Meeting Type: ANNUAL |
||||
Ticker: IRWD
Security ID: 46333X108 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | Elect Director Mark Currie | Management | For | For |
1.2 | Elect Director Alexander Denner | Management | For | For |
1.3 | Elect Director Andrew Dreyfus | Management | For | For |
1.4 | Elect Director Jon Duane | Management | For | For |
1.5 | Elect Director Marla Kessler | Management | For | For |
1.6 | Elect Director Thomas McCourt | Management | For | For |
1.7 | Elect Director Julie McHugh | Management | For | For |
1.8 | Elect Director Catherine Moukheibir | Management | For | For |
1.9 | Elect Director Jay Shepard | Management | For | For |
2 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
3 | Ratify Ernst & Young LLP as Auditors | Management | For | For |
JOHNSON & JOHNSON
Meeting Date: APR 28, 2022 Record Date: MAR 01, 2022 Meeting Type: ANNUAL |
||||
Ticker: JNJ
Security ID: 478160104 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Darius Adamczyk | Management | For | For |
1b | Elect Director Mary C. Beckerle | Management | For | For |
1c | Elect Director D. Scott Davis | Management | For | For |
1d | Elect Director Ian E. L. Davis | Management | For | For |
1e | Elect Director Jennifer A. Doudna | Management | For | For |
1f | Elect Director Joaquin Duato | Management | For | For |
1g | Elect Director Alex Gorsky | Management | For | For |
1h | Elect Director Marillyn A. Hewson | Management | For | For |
1i | Elect Director Hubert Joly | Management | For | For |
1j | Elect Director Mark B. McClellan | Management | For | For |
1k | Elect Director Anne M. Mulcahy | Management | For | For |
1l | Elect Director A. Eugene Washington | Management | For | For |
1m | Elect Director Mark A. Weinberger | Management | For | For |
1n | Elect Director Nadja Y. West | Management | For | For |
2 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
3 | Approve Omnibus Stock Plan | Management | For | For |
4 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | For | For |
5 | Adopt a Mandatory Arbitration Bylaw *Withdrawn Resolution* | Shareholder | None | None |
6 | Report on a Civil Rights, Equity, Diversity and Inclusion Audit | Shareholder | Against | Against |
7 | Oversee and Report a Racial Equity Audit | Shareholder | Against | For |
8 | Report on Government Financial Support and Access to COVID-19 Vaccines and Therapeutics | Shareholder | Against | For |
9 | Report on Public Health Costs of Limited Sharing of Vaccine Technology | Shareholder | Against | Against |
10 | Discontinue Global Sales of Baby Powder Containing Talc | Shareholder | Against | Against |
11 | Report on Charitable Contributions | Shareholder | Against | Against |
12 | Publish Third-Party Review of Alignment of Company's Lobbying Activities with its Public Statements | Shareholder | Against | For |
13 | Adopt Policy to Include Legal and Compliance Costs in Incentive Compensation Metrics | Shareholder | Against | Against |
14 | Consider Pay Disparity Between Executives and Other Employees | Shareholder | Against | Against |
LONZA GROUP AG
Meeting Date: MAY 05, 2022 Record Date: Meeting Type: ANNUAL |
||||
Ticker: LONN
Security ID: H50524133 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Accept Financial Statements and Statutory Reports | Management | For | Did Not Vote |
2 | Approve Remuneration Report | Management | For | Did Not Vote |
3 | Approve Discharge of Board and Senior Management | Management | For | Did Not Vote |
4 | Approve Allocation of Income and Dividends of CHF 3.00 per Share | Management | For | Did Not Vote |
5.1.1 | Reelect Albert Baehny as Director | Management | For | Did Not Vote |
5.1.2 | Reelect Angelica Kohlmann as Director | Management | For | Did Not Vote |
5.1.3 | Reelect Christoph Maeder as Director | Management | For | Did Not Vote |
5.1.4 | Reelect Barbara Richmond as Director | Management | For | Did Not Vote |
5.1.5 | Reelect Juergen Steinemann as Director | Management | For | Did Not Vote |
5.1.6 | Reelect Olivier Verscheure as Director | Management | For | Did Not Vote |
5.2.1 | Elect Marion Helmes as Director | Management | For | Did Not Vote |
5.2.2 | Elect Roger Nitsch as Director | Management | For | Did Not Vote |
5.3 | Reelect Albert Baehny as Board Chair | Management | For | Did Not Vote |
5.4.1 | Reappoint Angelica Kohlmann as Member of the Nomination and Compensation Committee | Management | For | Did Not Vote |
5.4.2 | Reappoint Christoph Maeder as Member of the Nomination and Compensation Committee | Management | For | Did Not Vote |
5.4.3 | Reappoint Juergen Steinemann as Member of the Nomination and Compensation Committee | Management | For | Did Not Vote |
6 | Ratify KPMG Ltd as Auditors | Management | For | Did Not Vote |
7 | Designate ThomannFischer as Independent Proxy | Management | For | Did Not Vote |
8 | Approve Remuneration of Directors in the Amount of CHF 2.9 Million | Management | For | Did Not Vote |
9.1 | Approve Fixed Remuneration of Executive Committee in the Amount of CHF 6.5 Million for the Period July 1, 2022 - June 30, 2023 | Management | For | Did Not Vote |
9.2 | Approve Variable Short-Term Remuneration of Executive Committee in the Amount of CHF 4.9 Million for Fiscal Year 2021 | Management | For | Did Not Vote |
9.3 | Approve Variable Long-Term Remuneration of Executive Committee in the Amount of CHF 11.1 Million for Fiscal Year 2022 | Management | For | Did Not Vote |
10 | Transact Other Business (Voting) | Management | For | Did Not Vote |
MCKESSON CORPORATION
Meeting Date: JUL 23, 2021 Record Date: MAY 28, 2021 Meeting Type: ANNUAL |
||||
Ticker: MCK
Security ID: 58155Q103 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Dominic J. Caruso | Management | For | For |
1b | Elect Director Donald R. Knauss | Management | For | For |
1c | Elect Director Bradley E. Lerman | Management | For | For |
1d | Elect Director Linda P. Mantia | Management | For | For |
1e | Elect Director Maria Martinez | Management | For | For |
1f | Elect Director Edward A. Mueller | Management | For | For |
1g | Elect Director Susan R. Salka | Management | For | For |
1h | Elect Director Brian S. Tyler | Management | For | For |
1i | Elect Director Kenneth E. Washington | Management | For | For |
2 | Ratify Deloitte & Touche LLP as Auditors | Management | For | For |
3 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
4 | Provide Right to Act by Written Consent | Shareholder | Against | Against |
MEDTRONIC PLC
Meeting Date: DEC 09, 2021 Record Date: OCT 14, 2021 Meeting Type: ANNUAL |
||||
Ticker: MDT
Security ID: G5960L103 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Richard H. Anderson | Management | For | For |
1b | Elect Director Craig Arnold | Management | For | For |
1c | Elect Director Scott C. Donnelly | Management | For | For |
1d | Elect Director Andrea J. Goldsmith | Management | For | For |
1e | Elect Director Randall J. Hogan, III | Management | For | For |
1f | Elect Director Kevin E. Lofton | Management | For | For |
1g | Elect Director Geoffrey S. Martha | Management | For | For |
1h | Elect Director Elizabeth G. Nabel | Management | For | For |
1i | Elect Director Denise M. O'Leary | Management | For | For |
1j | Elect Director Kendall J. Powell | Management | For | For |
2 | Approve PricewaterhouseCoopers LLP as Auditors and Authorize Board to Fix Their Remuneration | Management | For | For |
3 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
4 | Advisory Vote on Say on Pay Frequency | Management | One Year | One Year |
5 | Approve Omnibus Stock Plan | Management | For | For |
6 | Renew the Board's Authority to Issue Shares Under Irish Law | Management | For | For |
7 | Renew the Board's Authority to Opt-Out of Statutory Pre-Emptions Rights Under Irish Law | Management | For | For |
8 | Authorize Overseas Market Purchases of Ordinary Shares | Management | For | For |
MERCK & CO., INC.
Meeting Date: MAY 24, 2022 Record Date: MAR 25, 2022 Meeting Type: ANNUAL |
||||
Ticker: MRK
Security ID: 58933Y105 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Douglas M. Baker, Jr. | Management | For | For |
1b | Elect Director Mary Ellen Coe | Management | For | For |
1c | Elect Director Pamela J. Craig | Management | For | For |
1d | Elect Director Robert M. Davis | Management | For | For |
1e | Elect Director Kenneth C. Frazier | Management | For | For |
1f | Elect Director Thomas H. Glocer | Management | For | For |
1g | Elect Director Risa J. Lavizzo-Mourey | Management | For | For |
1h | Elect Director Stephen L. Mayo | Management | For | For |
1i | Elect Director Paul B. Rothman | Management | For | For |
1j | Elect Director Patricia F. Russo | Management | For | For |
1k | Elect Director Christine E. Seidman | Management | For | For |
1l | Elect Director Inge G. Thulin | Management | For | For |
1m | Elect Director Kathy J. Warden | Management | For | For |
1n | Elect Director Peter C. Wendell | Management | For | For |
2 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
3 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | For | For |
4 | Require Independent Board Chair | Shareholder | Against | Against |
5 | Report on Access to COVID-19 Products | Shareholder | Against | Against |
6 | Report on Lobbying Payments and Policy | Shareholder | Against | Against |
MERCK KGAA
Meeting Date: APR 22, 2022 Record Date: MAR 31, 2022 Meeting Type: ANNUAL |
||||
Ticker: MRK
Security ID: D5357W103 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Receive Financial Statements and Statutory Reports for Fiscal Year 2021 (Non-Voting) | Management | None | None |
2 | Accept Financial Statements and Statutory Reports for Fiscal Year 2021 | Management | For | For |
3 | Approve Allocation of Income and Dividends of EUR 1.85 per Share | Management | For | For |
4 | Approve Discharge of Management Board for Fiscal Year 2021 | Management | For | For |
5 | Approve Discharge of Supervisory Board for Fiscal Year 2021 | Management | For | For |
6 | Ratify KPMG AG as Auditors for Fiscal Year 2022 and for the Review of Interim Financial Reports for Fiscal Year 2022 | Management | For | For |
7 | Ratify Deloitte GmbH as Auditors for Fiscal Year 2023 and for the Review of Interim Financial Reports for Fiscal Year 2023 | Management | For | For |
8 | Approve Remuneration Report | Management | For | For |
9 | Approve Creation of EUR 56.5 Million Pool of Authorized Capital with or without Exclusion of Preemptive Rights | Management | For | For |
NOVARTIS AG
Meeting Date: MAR 04, 2022 Record Date: Meeting Type: ANNUAL |
||||
Ticker: NOVN
Security ID: H5820Q150 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Accept Financial Statements and Statutory Reports | Management | For | Did Not Vote |
2 | Approve Discharge of Board and Senior Management | Management | For | Did Not Vote |
3 | Approve Allocation of Income and Dividends of CHF 3.10 per Share | Management | For | Did Not Vote |
4 | Approve CHF 15.3 Million Reduction in Share Capital via Cancellation of Repurchased Shares | Management | For | Did Not Vote |
5 | Authorize Repurchase of up to CHF 10 Billion in Issued Share Capital | Management | For | Did Not Vote |
6.1 | Approve Remuneration of Directors in the Amount of CHF 8.6 Million | Management | For | Did Not Vote |
6.2 | Approve Maximum Remuneration of Executive Committee in the Amount of CHF 91 Million | Management | For | Did Not Vote |
6.3 | Approve Remuneration Report | Management | For | Did Not Vote |
7.1 | Reelect Joerg Reinhardt as Director and Board Chairman | Management | For | Did Not Vote |
7.2 | Reelect Nancy Andrews as Director | Management | For | Did Not Vote |
7.3 | Reelect Ton Buechner as Director | Management | For | Did Not Vote |
7.4 | Reelect Patrice Bula as Director | Management | For | Did Not Vote |
7.5 | Reelect Elizabeth Doherty as Director | Management | For | Did Not Vote |
7.6 | Reelect Bridgette Heller as Director | Management | For | Did Not Vote |
7.7 | Reelect Frans van Houten as Director | Management | For | Did Not Vote |
7.8 | Reelect Simon Moroney as Director | Management | For | Did Not Vote |
7.9 | Reelect Andreas von Planta as Director | Management | For | Did Not Vote |
7.10 | Reelect Charles Sawyers as Director | Management | For | Did Not Vote |
7.11 | Reelect William Winters as Director | Management | For | Did Not Vote |
7.12 | Elect Ana de Pro Gonzalo as Director | Management | For | Did Not Vote |
7.13 | Elect Daniel Hochstrasser as Director | Management | For | Did Not Vote |
8.1 | Reappoint Patrice Bula as Member of the Compensation Committee | Management | For | Did Not Vote |
8.2 | Reappoint Bridgette Heller as Member of the Compensation Committee | Management | For | Did Not Vote |
8.3 | Reappoint Simon Moroney as Member of the Compensation Committee | Management | For | Did Not Vote |
8.4 | Reappoint William Winters as Member of the Compensation Committee | Management | For | Did Not Vote |
9 | Ratify KPMG AG as Auditors | Management | For | Did Not Vote |
10 | Designate Peter Zahn as Independent Proxy | Management | For | Did Not Vote |
11 | Transact Other Business (Voting) | Management | For | Did Not Vote |
NOVO NORDISK A/S
Meeting Date: MAR 24, 2022 Record Date: MAR 17, 2022 Meeting Type: ANNUAL |
||||
Ticker: NOVO.B
Security ID: K72807132 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Receive Report of Board | Management | None | None |
2 | Accept Financial Statements and Statutory Reports | Management | For | Did Not Vote |
3 | Approve Allocation of Income and Dividends of DKK 6.90 Per Share | Management | For | Did Not Vote |
4 | Approve Remuneration Report (Advisory Vote) | Management | For | Did Not Vote |
5.1 | Approve Remuneration of Directors for 2021 in the Aggregate Amount of DKK 17.1 Million | Management | For | Did Not Vote |
5.2 | Approve Remuneration of Directors for 2022 in the Amount of DKK 2.26 Million for the Chairman, DKK 1.51 Million for the Vice Chairman, and DKK 755,000 for Other Directors; Approve Remuneration for Committee Work | Management | For | Did Not Vote |
6.1 | Reelect Helge Lund as Director and Board Chair | Management | For | Did Not Vote |
6.2 | Reelect Henrik Poulsen as Director and Vice Chair | Management | For | Did Not Vote |
6.3a | Reelect Jeppe Christiansen as Director | Management | For | Did Not Vote |
6.3b | Reelect Laurence Debroux as Director | Management | For | Did Not Vote |
6.3c | Reelect Andreas Fibig as Director | Management | For | Did Not Vote |
6.3d | Reelect Sylvie Gregoire as Director | Management | For | Did Not Vote |
6.3e | Reelect Kasim Kutay as Director | Management | For | Did Not Vote |
6.3f | Reelect Martin Mackay as Director | Management | For | Did Not Vote |
6.3g | Elect Choi La Christina Law as New Director | Management | For | Did Not Vote |
7 | Ratify Deloitte as Auditors | Management | For | Did Not Vote |
8.1 | Approve DKK 6 Million Reduction in Share Capital via B Share Cancellation | Management | For | Did Not Vote |
8.2 | Authorize Share Repurchase Program | Management | For | Did Not Vote |
8.3 | Approve Creation of DKK 45.6 Million Pool of Capital with Preemptive Rights; Approve Creation of DKK 45.6 Million Pool of Capital without Preemptive Rights; Maximum Increase in Share Capital under Both Authorizations up to DKK 45.6 Million | Management | For | Did Not Vote |
8.4 | Amendment to Remuneration Policy for Board of Directors and Executive Management | Management | For | Did Not Vote |
8.5 | Amend Articles Re: Board-Related | Management | For | Did Not Vote |
9 | Other Business | Management | None | None |
OPTION CARE HEALTH, INC.
Meeting Date: MAY 18, 2022 Record Date: MAR 22, 2022 Meeting Type: ANNUAL |
||||
Ticker: OPCH
Security ID: 68404L201 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | Elect Director Anita M. Allemand | Management | For | For |
1.2 | Elect Director John J. Arlotta | Management | For | For |
1.3 | Elect Director Elizabeth Q. Betten | Management | For | For |
1.4 | Elect Director Elizabeth D. Bierbower | Management | For | For |
1.5 | Elect Director Natasha Deckmann | Management | For | For |
1.6 | Elect Director Aaron Friedman | Management | For | For |
1.7 | Elect Director David W. Golding | Management | For | For |
1.8 | Elect Director Harry M. Jansen Kraemer, Jr. | Management | For | For |
1.9 | Elect Director R. Carter Pate | Management | For | For |
1.10 | Elect Director John C. Rademacher | Management | For | For |
1.11 | Elect Director Nitin Sahney | Management | For | For |
1.12 | Elect Director Timothy Sullivan | Management | For | For |
1.13 | Elect Director Mark Vainisi | Management | For | For |
2 | Ratify KPMG LLP as Auditors | Management | For | For |
3 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
PFIZER INC.
Meeting Date: APR 28, 2022 Record Date: MAR 02, 2022 Meeting Type: ANNUAL |
||||
Ticker: PFE
Security ID: 717081103 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1.1 | Elect Director Ronald E. Blaylock | Management | For | For |
1.2 | Elect Director Albert Bourla | Management | For | For |
1.3 | Elect Director Susan Desmond-Hellmann | Management | For | For |
1.4 | Elect Director Joseph J. Echevarria | Management | For | For |
1.5 | Elect Director Scott Gottlieb | Management | For | For |
1.6 | Elect Director Helen H. Hobbs | Management | For | For |
1.7 | Elect Director Susan Hockfield | Management | For | For |
1.8 | Elect Director Dan R. Littman | Management | For | For |
1.9 | Elect Director Shantanu Narayen | Management | For | For |
1.10 | Elect Director Suzanne Nora Johnson | Management | For | For |
1.11 | Elect Director James Quincey | Management | For | For |
1.12 | Elect Director James C. Smith | Management | For | For |
2 | Ratify KPMG LLP as Auditors | Management | For | For |
3 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
4 | Amend Proxy Access Right | Shareholder | Against | Against |
5 | Report on Congruency of Political Electioneering Expenditures with Company Values and Policies | Shareholder | Against | Against |
6 | Report on Feasibility of Technology Transfer to Boost Covid-19 Vaccine Production | Shareholder | Against | Against |
7 | Report on Board Oversight of Risks Related to Anticompetitive Practices | Shareholder | Against | Against |
8 | Report on Public Health Costs of Limited Sharing of Vaccine Technology | Shareholder | Against | Against |
SANOFI
Meeting Date: MAY 03, 2022 Record Date: APR 29, 2022 Meeting Type: ANNUAL/SPECIAL |
||||
Ticker: SAN
Security ID: F5548N101 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Approve Financial Statements and Statutory Reports | Management | For | For |
2 | Approve Consolidated Financial Statements and Statutory Reports | Management | For | For |
3 | Approve Allocation of Income and Dividends of EUR 3.33 per Share | Management | For | For |
4 | Reelect Paul Hudson as Director | Management | For | For |
5 | Reelect Christophe Babule as Director | Management | For | For |
6 | Reelect Patrick Kron as Director | Management | For | For |
7 | Reelect Gilles Schnepp as Director | Management | For | For |
8 | Elect Carole Ferrand as Director | Management | For | For |
9 | Elect Emile Voest as Director | Management | For | For |
10 | Elect Antoine Yver as Director | Management | For | For |
11 | Approve Compensation Report of Corporate Officers | Management | For | For |
12 | Approve Compensation of Serge Weinberg, Chairman of the Board | Management | For | For |
13 | Approve Compensation of Paul Hudson, CEO | Management | For | For |
14 | Approve Remuneration Policy of Directors | Management | For | For |
15 | Approve Remuneration Policy of Chairman of the Board | Management | For | For |
16 | Approve Remuneration Policy of CEO | Management | For | For |
17 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital | Management | For | For |
18 | Amend Article 25 of Bylaws Re: Dividends | Management | For | For |
19 | Authorize Filing of Required Documents/Other Formalities | Management | For | For |
TAKEDA PHARMACEUTICAL CO., LTD.
Meeting Date: JUN 29, 2022 Record Date: MAR 31, 2022 Meeting Type: ANNUAL |
||||
Ticker: 4502
Security ID: J8129E108 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Approve Allocation of Income, with a Final Dividend of JPY 90 | Management | For | For |
2 | Amend Articles to Disclose Shareholder Meeting Materials on Internet | Management | For | For |
3.1 | Elect Director Christophe Weber | Management | For | For |
3.2 | Elect Director Iwasaki, Masato | Management | For | For |
3.3 | Elect Director Andrew Plump | Management | For | For |
3.4 | Elect Director Constantine Saroukos | Management | For | For |
3.5 | Elect Director Olivier Bohuon | Management | For | For |
3.6 | Elect Director Jean-Luc Butel | Management | For | For |
3.7 | Elect Director Ian Clark | Management | For | For |
3.8 | Elect Director Steven Gillis | Management | For | For |
3.9 | Elect Director Iijima, Masami | Management | For | For |
3.10 | Elect Director John Maraganore | Management | For | For |
3.11 | Elect Director Michel Orsinger | Management | For | For |
4.1 | Elect Director and Audit Committee Member Hatsukawa, Koji | Management | For | For |
4.2 | Elect Director and Audit Committee Member Higashi, Emiko | Management | For | For |
4.3 | Elect Director and Audit Committee Member Fujimori, Yoshiaki | Management | For | For |
4.4 | Elect Director and Audit Committee Member Kimberly Reed | Management | For | For |
5 | Approve Annual Bonus | Management | For | For |
TERRASCEND CORP.
Meeting Date: NOV 11, 2021 Record Date: OCT 04, 2021 Meeting Type: SPECIAL |
||||
Ticker: TER
Security ID: 88105E108 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Issue Shares in Connection with Acquisition of Gage Growth Corp. | Management | For | For |
TERRASCEND CORP.
Meeting Date: JUN 27, 2022 Record Date: APR 28, 2022 Meeting Type: ANNUAL |
||||
Ticker: TER
Security ID: 88105E108 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Craig Collard | Management | For | Withhold |
1b | Elect Director Kara DioGuardi | Management | For | Withhold |
1c | Elect Director Ed Schutter | Management | For | Withhold |
1d | Elect Director Lisa Swartzman | Management | For | Withhold |
1e | Elect Director Jason Wild | Management | For | Withhold |
2 | Approve MNP LLP as Auditors and Authorize Board to Fix Their Remuneration | Management | For | For |
TERUMO CORP.
Meeting Date: JUN 22, 2022 Record Date: MAR 31, 2022 Meeting Type: ANNUAL |
||||
Ticker: 4543
Security ID: J83173104 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Approve Allocation of Income, with a Final Dividend of JPY 18 | Management | For | For |
2 | Amend Articles to Disclose Shareholder Meeting Materials on Internet | Management | For | For |
3.1 | Elect Director Takagi, Toshiaki | Management | For | For |
3.2 | Elect Director Sato, Shinjiro | Management | For | For |
3.3 | Elect Director Hatano, Shoji | Management | For | For |
3.4 | Elect Director Nishikawa, Kyo | Management | For | For |
3.5 | Elect Director Hirose, Kazunori | Management | For | For |
3.6 | Elect Director Kuroda, Yukiko | Management | For | For |
3.7 | Elect Director Nishi, Hidenori | Management | For | For |
3.8 | Elect Director Ozawa, Keiya | Management | For | For |
4 | Elect Alternate Director and Audit Committee Member Sakaguchi, Koichi | Management | For | For |
THERMO FISHER SCIENTIFIC INC.
Meeting Date: MAY 18, 2022 Record Date: MAR 25, 2022 Meeting Type: ANNUAL |
||||
Ticker: TMO
Security ID: 883556102 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Marc N. Casper | Management | For | For |
1b | Elect Director Nelson J. Chai | Management | For | For |
1c | Elect Director Ruby R. Chandy | Management | For | For |
1d | Elect Director C. Martin Harris | Management | For | For |
1e | Elect Director Tyler Jacks | Management | For | For |
1f | Elect Director R. Alexandra Keith | Management | For | For |
1g | Elect Director Jim P. Manzi | Management | For | For |
1h | Elect Director James C. Mullen | Management | For | For |
1i | Elect Director Lars R. Sorensen | Management | For | For |
1j | Elect Director Debora L. Spar | Management | For | For |
1k | Elect Director Scott M. Sperling | Management | For | For |
1l | Elect Director Dion J. Weisler | Management | For | For |
2 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
3 | Ratify PricewaterhouseCoopers LLP as Auditors | Management | For | For |
UNITED THERAPEUTICS CORPORATION
Meeting Date: SEP 30, 2021 Record Date: AUG 10, 2021 Meeting Type: SPECIAL |
||||
Ticker: UTHR
Security ID: 91307C102 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1 | Amend Certificate of Incorporation to become a Public Benefit Corporation | Management | For | For |
UNITEDHEALTH GROUP INCORPORATED
Meeting Date: JUN 06, 2022 Record Date: APR 08, 2022 Meeting Type: ANNUAL |
||||
Ticker: UNH
Security ID: 91324P102 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Timothy P. Flynn | Management | For | For |
1b | Elect Director Paul R. Garcia | Management | For | For |
1c | Elect Director Stephen J. Hemsley | Management | For | For |
1d | Elect Director Michele J. Hooper | Management | For | For |
1e | Elect Director F. William McNabb, III | Management | For | For |
1f | Elect Director Valerie C. Montgomery Rice | Management | For | For |
1g | Elect Director John H. Noseworthy | Management | For | For |
1h | Elect Director Andrew Witty | Management | For | For |
2 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
3 | Ratify Deloitte & Touche LLP as Auditors | Management | For | For |
4 | Submit Severance Agreement (Change-in-Control) to Shareholder Vote | Shareholder | Against | Against |
5 | Report on Congruency of Political Spending with Company Values and Priorities | Shareholder | Against | Against |
ZOETIS INC.
Meeting Date: MAY 19, 2022 Record Date: MAR 25, 2022 Meeting Type: ANNUAL |
||||
Ticker: ZTS
Security ID: 98978V103 |
||||
Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
1a | Elect Director Paul M. Bisaro | Management | For | For |
1b | Elect Director Frank A. D'Amelio | Management | For | For |
1c | Elect Director Michael B. McCallister | Management | For | For |
2 | Advisory Vote to Ratify Named Executive Officers' Compensation | Management | For | For |
3 | Amend Omnibus Stock Plan | Management | For | For |
4 | Ratify KPMG LLP as Auditors | Management | For | For |
5 | Eliminate Supermajority Vote Requirements | Management | For | For |
6 | Declassify the Board of Directors | Management | For | For |
Any ballot marked 'Abstain' is considered to have been voted. Ballots marked 'Abstain' are considered to have been voted against management's recommendation if management's recommendation is 'For' or 'Against,' and for management's recommendation if management's recommendation is 'Abstain.' Where management has recommended that shareholders 'Abstain' from voting on a ballot item, a ballot marked 'For' or 'Against' is considered to have been voted against management's recommendation to 'Abstain.'
Where management has made no recommendation on a ballot item, 'N/A' is used to indicate that there is no management recommendation that a shareholder may vote 'For' or 'Against.'
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
REGISTRANT: Putnam Global Health Care Fund
BY: /s/Jonathan S. Horowitz
NAME: Jonathan S. Horowitz
TITLE: Executive Vice President, Principal Executive Officer and Compliance Liaison
DATE: AUGUST 12, 2022